J Biol Chem, Vol. 274, Issue 42, 29755-29762, October 15, 1999
Reactivity of Tetrahydrobiopterin Bound to Nitric-oxide
Synthase*
Cor F. B.
Witteveen,
John
Giovanelli
, and
Seymour
Kaufman
From the Laboratory of Neurochemistry, National Institute of Mental
Health, Bethesda, Maryland 20892-4096
 |
ABSTRACT |
Levels of tetrahydrobiopterin
(BH4) bound to nitric-oxide synthase (NOS) were
examined during multiple turnovers of the enzyme in the presence of an
NADPH-regenerating system. Our findings show that NOS-bound
BH4 does not remain in a static state but undergoes redox
reactions. Under these experimental conditions, the redox state of
BH4 was determined by the balance between
calcium/calmodulin (Ca2+/CaM)-dependent
oxidation of BH4 mediated by the uncoupled formation of
superoxide/hydrogen peroxide on the one hand and by reductive regeneration of BH4 on the other hand. BH4
oxidation was appreciably increased in the presence of arginine. Levels
of NOS-bound BH4 were also examined under single turnover
conditions in the absence of an NADPH-regenerating system and in the
presence of added superoxide dismutase and catalase to suppress the
accumulation of superoxide and hydrogen peroxide. BH4
oxidation was again dependent on Ca2+/CaM. The
insensitivity to superoxide dismutase and catalase suggested that the
single turnover oxidation of BH4 did not proceed through superoxide/peroxide, although the involvement of these oxidants could
not be definitively excluded. The amount of BH4 oxidized was highest in the presence of arginine, and this oxidation
significantly exceeded that in the presence of
NG-hydroxy-L-arginine. The findings
that single turnover oxidation of BH4 is stimulated by
arginine in the presence of Ca2+/CaM and that
BH4 is regenerated are consistent with a role for the
pterin as an electron donor in product formation; this role remains to
be defined.
 |
INTRODUCTION |
Nitric-oxide synthase
(NOS)1 catalyzes the overall
conversion of arginine to nitric oxide (NO) and citrulline. The
reaction proceeds in two steps; arginine is first oxygenated to the
intermediate NG-hydroxy-L-arginine
(NHA), which is then oxygenated to the products NO and citrulline
(reviewed in Ref. 1). The enzyme has attracted much interest because of
its involvement in a variety of physiological processes such as
vasodilation, cytotoxic activity, and neurotransmission (2, 3). NOS is
unique as a heme oxygenase in requiring BH4, and
elucidation of the role of BH4 is essential in
understanding how this enzyme functions.
It is well established that BH4 has pronounced effects on
the structure of NOS. These effects include the ability to shift the
heme iron to its high spin state, promotion of arginine binding, and
stabilization of the active dimeric form of the enzyme (reviewed in
Ref. 4), as well as stabilization of the ferrous heme iron coordination
structure (5). Furthermore, binding of the first molecule of
BH4 to an NOS dimer has an anticooperative effect on the
binding of the second molecule of BH4 (6). Studies of the
effects of pterin analogues on NOS provide graphic evidence that these
structural effects cannot fully explain the requirement for
BH4. Whereas the structural effects of BH4 are
mimicked by a series of pterin analogues independent of their oxidation
state, pterins must be in the tetrahydro state in order to support NO synthesis (5, 7, 8). This requirement for a tetrahydropterin suggests
an additional, redox, role of BH4.
A number of recent reports support a redox role of BH4 in
which the pterin provides electrons for the oxygenation reactions catalyzed by NOS. Studies with recombinant BH4-free NOS (9) have implicated BH4 as acting as a stoichiometric reactant
in the first oxygenation step (arginine to NHA) of NO synthesis. The
role of BH4 in this reaction is envisioned by Rusche
et al. (9) as being analogous to the well established role
of BH4 in the aromatic amino acid hydroxylase systems (10),
except that BH4 remains tightly bound to NOS throughout the
catalytic cycle (11). Further support for this proposal is provided by the finding that non-heme iron, which is an integral component of the
aromatic amino acid hydroxylases (10), is a stoichiometric component of
NOS and enhances its activity (12). Again by analogy with the
hydroxylation of the aromatic amino acids (10), the oxidation of
BH4 by NOS would generate equivalent amounts of NHA and
quinonoid dihydrobiopterin (qBH2), and the latter compound would need to be recycled to BH4 by a dihydropterin
reductase-like activity in order to maintain the catalytic function of
BH4. In these same studies, Rusche et al. (9)
further proposed a role for BH4 in the second oxygenation
step (NHA to citrulline and NO). It was suggested (9) that
BH4 may be acting as an electron donor in this step or in
an indirect fashion by affecting, for example, the spin equilibrium and
reduction potential of the heme.
Further support for a redox role of BH4 is provided by the
single turnover studies of NOS (13). It was suggested that
BH4 plays a critical role in the first oxygenation step by
supplying an electron for reducing the ferric heme superoxide species
to the ferric heme peroxo species. Based largely on studies of
cytochrome P-450, the latter species, or a closely related form, is
believed to carry out the oxygenation of arginine (1, 14). Since only one electron is required for reduction of the ferric heme superoxide species to the ferric heme peroxo species by BH4, the
oxidized pterin product was formally represented as the
trihydrobiopterin radical (BH3·),
although the possibility of qBH2 being the product could
not be excluded. Based on crystallographic studies and the unexpected finding that arginine recognizes the BH4-binding site,
Raman et al. (15) suggest that this site may stabilize the
positively charged pterin cation radical, thereby supporting a scheme
in which electrons are shuttled between the protonated forms of
BH4 and BH3·, rather than
between BH4 and qBH2. It has recently been
reported (16) that the 5-methyl analogue of BH4 is
functionally active with NOS but does not react with oxygen or
stimulate phenylalanine hydroxylase. It is suggested (16) on the basis
of these studies that the redox chemistry of BH4 is not the
same in NOS as it is in the aromatic amino acid hydroxylases, but it
could not be excluded that BH4 interacts with the heme or
another metal group of NOS through an as yet unrecognized redox chemistry.
Since catalytic amounts of BH4 are sufficient for NOS
activity (11), a minimum requirement for any role of BH4 as
a reductant is that the oxidized pterin products be regenerated with
each catalytic cycle by a dihydropterin reductase-like activity
intrinsic to the enzyme. No recycling of exogenous
BH4 was detected during NOS turnover (11), but this study
did not exclude the possibility of recycling of BH4 tightly
bound to the enzyme (17). The reduction of added qBH2 to
BH4 by NOS, probably by the flavoprotein "diaphorase" activity of the enzyme, has been demonstrated (18), but the significance of this finding to the essential role of BH4 was uncertain. Furthermore, under the standard assay conditions of this
latter study, any regenerated BH4 that remains firmly bound to NOS would not have been detected, since any such regeneration is
limited to the number of BH4-binding sites; these sites are negligible relative to the observed amounts of qBH2 reduced.
The present work provides experimental support for a redox role of
BH4 by showing that NOS-bound BH4 can cycle
with its oxidized form(s). Although details of the oxidation
of BH4 remain to be clarified, this work is an important
step toward defining the mechanistic significance of this reaction in
NO formation. The regeneration of BH4 from its
oxidized products is probably important in maintaining the pterin in
its active, tetrahydro, state.
 |
EXPERIMENTAL PROCEDURES |
Chemicals--
The following materials were obtained from the
sources shown in parentheses:
NG-nitro-L-arginine (NNA) and
L-
-lysolecithin (Sigma), CaM from bovine brain
(Calbiochem), BH4 (B. Schircks Laboratories, Jona, Switzerland), L-[2,6-3H]phenylalanine,
L-[2,3,4,5-3H]arginine, and
L-[U-14C]tyrosine (Amersham Pharmacia
Biotech), and NHA (Alexis Corp., San Diego, CA),
Enzymes--
Beef liver catalase was obtained from Roche
Molecular Biochemicals. Superoxide dismutase (SOD) from bovine
erythrocytes and glucose-6-phosphate dehydrogenase from
Leuconostoc mesenteroides were obtained from Sigma.
Recombinant rat phenylalanine hydroxylase was prepared by minor
modification (19) of the procedure of Citron et al. (20) and
had a specific activity of approximately 2 µmol/min/mg. Rat brain NOS
was purified from transfected human kidney 293 cells (21). NOS isolated
in this way showed a single band on an SDS-polyacrylamide gel and
typically had a specific activity of 1.0-1.6 µmol/min/mg as
determined by citrulline formation over a 10-min incubation at 37 °C
with the assay of Bredt and Snyder (22). Molar concentrations of NOS
are reported for the 160-kDa subunit. The BH4 content of
the purified NOS was typically 0.5 mol/mol subunit as determined by
high performance liquid chromatography (HPLC) analysis of oxidized
samples (23). Protein was determined by the bicinchoninic acid method
(Pierce manual 23225X) with the use of a bovine serum albumin standard.
BH4 Levels during Turnover of NOS--
Reaction
mixtures used for these studies contained 1 µM NADPH and
an NADPH-regenerating system. This low concentration of NADPH was used
to prevent significant non-enzymic regeneration of BH4 that
occurs at higher concentrations of NADPH (18, 24). We have previously
shown (18) that NOS has normal activity using this low concentration of
NADPH. The standard reaction mixture contained 2 µM NOS,
1 µM NADPH, 1.5 mM glucose 6-phosphate, 32 µg/ml glucose-6-phosphate dehydrogenase, 35 mM sodium
Bicine (pH 7.6), 0.9 mM CaCl2, and 0.6 mM EDTA. The following components were also added as
indicated: 4 µM CaM, 800 µg/ml SOD, 16 µg/ml catalase, 50 µM arginine or NHA, and 200 µM
NNA. In some experiments, reaction mixtures were supplemented with a
concentration of BH4 equal to one-half the concentration of
NOS monomer. In this way, native NOS containing approximately 0.5 BH4/NOS monomer was reconstituted to approach a value of
1/NOS monomer.2 Incubations
were at 15 °C. Samples of 25 µl were taken to establish the
initial levels of BH4. Immediately thereafter, CaM was
added, where appropriate, in order to start the reaction, and samples of 25 µl were taken at fixed times for BH4 analysis. As
illustrated under "Results," negligible oxidation of
BH4 occurred in the absence of CaM.
BH4 Levels under Single Turnover Conditions--
Two
different procedures were followed depending on whether only
BH4 levels were determined or whether BH4
levels together with NHA were determined.
The standard reaction mixture in which only BH4 levels were
determined contained 1.7 µM NOS, 0.9 mM
CaCl2, 0.6 mM EDTA, 400 units/ml SOD, 8 µg/ml
catalase, and 50 mM sodium Hepes (pH 7.4). Where indicated,
NOS was reconstituted with BH4 as described above to
contain approximately 1 BH4/NOS subunit. Immediately prior to the start of the reaction, NADPH was added to the standard reaction
mixture (1 NADPH per NOS subunit), and the mixture preincubated for
2.25 min. This procedure, which is fully described in a separate section below, generated a maximum level of NOS-bound flavin
semiquinone. Separate experiments showed that BH4 was
stable during this preincubation period. After the preincubation,
samples were taken to establish initial BH4 levels.
Immediately thereafter, the indicated additions of 4 µM
CaM, 50 µM arginine, or 50 µM NHA were
made, and 25 µl samples for BH4 analysis removed at 30, 60, 120, and 180 s.
For determination of both BH4 and NHA, reaction mixtures
initially contained 3.4 µM NOS, 15 µM
L-arginine, 0.9 mM CaCl2, 0.6 mM EDTA, 800 units/ml SOD, 16 µg/ml catalase, and 50 mM sodium Hepes (pH 7.4). During the preincubation period
with 3.4 µM NADPH (see below), part of the reaction
mixture to be used for determination of NHA was transferred to a tube
containing L-[3H]arginine, resulting in an
increase in the arginine concentration to 18.4 µM. In the
other tube containing the remainder of the reaction mixture, unlabeled
arginine was added to achieve the same final concentration of 18.4 µM arginine; this tube was used for determination of
BH4 levels. Immediately after samples were taken to
establish initial levels of BH4 and NHA, CaM was added to a
final concentration of 4.7 µM to each tube, and 25-µl
samples were removed at the intervals shown above for determination of NHA formation and BH4. All additions were made in very
small volumes so as not to significantly change the specified
concentrations of reaction components.
All incubations were at 15 °C.
Determination of BH4 Oxidation--
BH4
was determined by coupling this pterin to the phenylalanine
hydroxylase-catalyzed conversion of an equivalent amount of [3H]phenylalanine to [3H]tyrosine.
Reproducibility of the original method (18) was improved by the
modifications described below. To the 25-µl samples taken from
reaction mixtures, 5 µl of 1.5 M HClO4 was
added immediately to stop the reaction, release BH4 from
NOS, and stabilize the pterin in its reduced form. Within 4 min after
adding the acid, 5 µl KHCO3 was added to partially
neutralize the mixture to approximately pH 2.5-3.0. The precipitate of
KClO4 was removed by a 10-s centrifugation, and 30 µl of
the supernatant solution was added to 9.6 µl of a solution containing
the remaining reaction components. The final reaction mixture
contained, in addition to the BH4 to be assayed, 1 µg of
phenylalanine hydroxylase, 4.8 µM
L-[3H]phenylalanine (6 µCi), 150 mM potassium phosphate (pH 6.5), 0.1 mM
lysolecithin to activate phenylalanine hydroxylase, 0.12 mg/ml
catalase, and 333 units/ml SOD. Incubation was for 30 min at 30 °C.
The reaction was stopped by adding 25 µl of a solution containing 273 mM HClO4, 0.73 mM
L-phenylalanine, and 0.73 mM L-[14C] tyrosine (30 nCi), the last component
being added to correct for losses during subsequent purification of
radioactive tyrosine by HPLC. HPLC was performed on a Beckman
Ultrasphere ODS column (C-18, 4.6 mm internal diameter × 150 mm,
5-µm particles) eluted isocratically with 5 mM sodium
acetate buffer (pH 4.8). The ratio of [3H] to
[14C] in tyrosine was used to calculate the amount of
[3H]tyrosine formed. For each experiment a separate
BH4 calibration curve was established with increasing
amounts of NOS either unsupplemented or supplemented with
BH4. The BH4 content of NOS samples used for
calibration was determined independently by the method of Fukushima and
Nixon (23).
Single Turnover Oxygenation of Arginine to NHA--
The
formation of NHA in the absence of added NADPH was measured by the
incorporation of 3H from
L-[3H]arginine into NHA (25).
Generation of FSQ by Addition of NADPH--
The air-stable
NOS-bound flavin semiquinone free radical, FMNH· (FSQ) was
generated immediately before use by preincubation of NOS for 2.25 min
in air with NADPH (26). One mol of NADPH (two electron eq) per mol of
NOS subunit was required to obtain the maximum level of FSQ (reduced at
the level of one electron eq), presumably to compensate for reaction of
reduced flavin species with oxygen during the titration. Total reduced
flavins were measured by the decrease in absorbance at 458 nm and FSQ
by the increase in absorbance at 590 nm (27). All absorbance values
were determined with a Hewlett-Packard 8453 diode array
spectrophotometer. Addition of NADPH typically resulted in an
instantaneous decrease in absorbance at 458 nm, followed by a slow
increase in absorbance (first order rate constant of 2.6 min
1) over the next 2 min to approach a constant value
approximately midway between the minimal and initial absorbance values.
Parallel measurements at 590 nm showed a slow increase in absorbance
throughout the incubation period (first order rate constant of 3.4 min
1) to approach a constant value. The combined results
are interpreted as reflecting a rapid reduction of the flavins
(presumably by formation of FADH2 and subsequently
FMNH2) followed by formation of a stable FMNH·
species resulting from the partial oxidation of FMNH2 by
oxygen. These spectral data are consistent with values 0.4-0.6
FMNH· per NOS subunit estimated from the amount of NHA formed
per NOS subunit (21). Gachhui et al. (27) similarly observed
approximately 0.5 FMNH· per reductase domain of NOS resulting
from titration of this domain with NADPH in air.
 |
RESULTS |
Levels of NOS-bound BH4 were examined under three
conditions of continuous turnover. In these experiments, continuous
turnover of neuronal NOS (nNOS) was achieved in the presence of a low
concentration (1 µM) of NADPH and an NADPH-regenerating
system. Clearly, in the absence of arginine, no NO is formed. Under
this fully uncoupled condition, electrons are transferred from NADPH to
oxygen with the exclusive formation of superoxide and peroxide (6,
28-30). In the presence of arginine, but no added BH4,
nNOS is partially coupled, resulting in the formation of both NO and
superoxide/peroxide (28, 30). Maximum coupling of NADPH oxidation to NO
formation is approached in the presence of saturating concentrations of both arginine and BH4 (6, 28). However, complete coupling of electron transfer from NADPH to NO formation in the presence of
arginine and BH4 would not be expected under our
conditions. This is because it appears that some superoxide is formed
even in the presence of saturating arginine and BH4 (31),
and the addition of BH4 in our studies resulted in
incomplete saturation2 of NOS with BH4.
BH4 Levels during Fully Uncoupled Turnover of
NOS--
Fig. 1 illustrates
representative results for the levels of NOS-bound BH4 in
the absence of added BH4 and arginine. In the absence of
CaM, the level of BH4 remains constant (curve
1). Addition of CaM results in approximately 40% oxidation
of BH4 (curve 2). CaM-dependent oxidation of BH4 is largely
prevented by the additional presence of SOD and catalase
(curve 3). Furthermore, the
CaM-dependent oxidation of BH4 proceeding over
an 80-s period (curve 4, open circles) is
partially reversed by addition of SOD and catalase, in combination with
NNA (curve 4, closed circles). NNA is
a potent inhibitor of heme-catalyzed reduction of oxygen by neuronal
NOS and the consequent formation of superoxide/hydrogen peroxide and nitric oxide (28, 29, 32, 33). Regeneration of BH4 did not
occur in the absence of NNA. These combined findings strongly suggest
that BH4 is oxidized by superoxide and/or peroxide
generated by NOS during the uncoupled reduction of oxygen by NADPH and
that regeneration of BH4 (possibly from qBH2)
proceeds when the concentration of superoxide/peroxide is decreased to
a low level in the combined presence of SOD, catalase, and NNA.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
BH4 levels during fully uncoupled
turnover of NOS. , curve 1, no additions
to the standard reaction mixture; , curve 2,
addition of CaM; , curve 3, addition of CaM,
SOD, and catalase; curve 4, addition of CaM
( ), followed by further addition of SOD, catalase and NNA after
80 s ( ). No measurements were taken during the period indicated
by the broken line. The standard reaction mixture and
concentration of all components are described under "Experimental
Procedures." BH4 levels are expressed as a percentage of
the initial values.
|
|
Effects of Supplementation with Arginine on BH4 Levels
during Turnover of NOS--
Fig. 2
compares the BH4 levels of NOS under partially coupled
conditions (presence of supplemental arginine) with those described above under fully uncoupled conditions (Fig. 1). Curves
1 and 2 of Fig. 2 confirm the requirement of CaM
for BH4 oxidation. BH4 levels are largely
stabilized by addition of NNA at the beginning of the incubation
(curve 3). In the presence of CaM, addition of
arginine markedly increased the oxidation of BH4 from 40%
(curve 2) to 80-90% (curve
4). Oxidation under the latter conditions (arginine and CaM)
was greatly attenuated by addition of SOD plus catalase
(curve 5), and partially reversed by addition of
SOD, catalase, and NNA (curve 6, closed circles
versus open circles), indicating that sufficient
superoxide/peroxide is generated even in the presence of supplemental
arginine to cause extensive oxidation of BH4.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 2.
Effects of supplemental arginine on
BH4 levels during NOS turnover. Conditions are the
same as in Fig. 1. , curve 1, no additions to
the standard reaction mixture; , curve 2,
addition of CaM; , curve 3, addition of CaM
and NNA; , curve 4, addition of CaM and
arginine; , curve 5, addition of CaM,
arginine, SOD, and catalase; curve 6, addition of
CaM and arginine ( ), followed by further addition of SOD, catalase,
and NNA after 80 s ( ). No measurements were taken during the
period indicated by the broken line.
|
|
Effects of Supplementation with Arginine and BH4 on BH4
Levels during Turnover of NOS--
Since maximum coupling is
approached in the combined presence of arginine and BH4 (6,
28), it was therefore of interest to determine the effect of adding
BH4 to the arginine-supplemented reaction mix used in the
experiment described in Fig. 2. The results shown in Fig.
3 confirm that little or no oxidation of
NOS-bound BH4 occurs in the absence of CaM
(curve 1) and further show that similar stability
of BH4 is observed in the presence of supplemental BH4 (curve 2).
CaM-dependent oxidation is increased marginally by
supplementary BH4 (curve 4 versus curve 3). In the presence of arginine,
supplementary BH4 initially protects BH4
against oxidation (curve 6 versus
curve 5), but this protective effect is lost as
the incubation progresses. These results show that even in the presence
of arginine and BH4, conditions that favor the coupled
formation of NO, BH4 is oxidized ultimately to the same low
level as observed with arginine alone.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
Effects of supplemental BH4 and
arginine on BH4 levels during NOS turnover. Native NOS
containing 0.5 BH4/NOS subunit was reconstituted with
supplemental BH4 to a value approaching 1 BH4/NOS subunit (see "Experimental Procedures").
BH4 levels are expressed as percentages of the initial
total BH4 content. Thus, although the amount of initial
total BH4 in the BH4-supplemented reaction
mixtures is twice that of the unsupplemented reaction mixtures, there
is also almost twice as much NOS containing bound BH4. This
representation allows direct approximation of relative BH4
levels based on the corresponding amount of BH4-bound NOS.
Conditions are the same as those described in Fig. 1 except for the
absence or presence, respectively, of supplemental BH4: and curves 1 and 2, no additions;
and , curves 3 and 4, plus CaM;
and , curves 5 and 6, plus CaM
and arginine.
|
|
BH4 Levels during Single Turnover of NOS--
In the
studies reported above, reaction mixtures contained an
NADPH-regenerating system that provides a source of electrons for both
the superoxide/peroxide-mediated oxidation of BH4 and, as
demonstrated in the presence of SOD plus catalase
plus NNA, the regeneration of BH4 from its
oxidized products. The effects noted above therefore represent
steady-state changes determined by the amount of oxidation of
BH4 on the one hand and regeneration of BH4 on
the other. Clearly, in order to detect any oxidation of BH4
that is stoichiometrically coupled with the overall oxygenation of
arginine to NO, it is necessary to prevent regeneration of BH4 from its oxidized products. We therefore examined
BH4 levels of NOS during the single turnover of arginine to
NHA and of NHA to citrulline in the absence of an NADPH-regenerating
system; SOD/catalase were included in the reaction mixtures to minimize any oxidation of BH4 by superoxide/peroxide.
Fig. 4 illustrates results of experiments
to determine the effects of arginine and NHA on BH4
oxidation. The possible trace amount of BH4 oxidation in
the absence of CaM (curve 1) could reflect the
inherent instability of BH4 under these conditions. Addition of CaM (curve 2) or CaM plus
NHA (curve 3) caused a small increase in the
oxidation. Maximal BH4 oxidation was observed in the
presence of CaM plus arginine (curve
4). Higher levels of SOD/catalase added to the reaction
mixture of curve 2 resulted in similar results
(data not shown).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
BH4 levels under single turnover
conditions. NOS was preincubated with NADPH to maximize the level
of FSQ, and reaction mixtures were supplemented with BH4.
Details are given under "Experimental Procedures." ,
curve 1, no additions; , curve 2, addition of CaM; , curve 3,
addition of CaM and NHA; , curve 4, addition
of CaM and arginine. Error bars indicate standard deviation
of at least three experiments.
|
|
The relationship between BH4 oxidation and oxygenation of
arginine to NHA under single turnover conditions is illustrated in Fig.
5. NHA, the immediate product of arginine
oxidation, was the dominant product; citrulline formation was
negligible (data not shown). The ratio of BH4 oxidized to
NHA formed was not constant. It may be estimated from the results of
Fig. 5 (inset) that this ratio increased with time from 1.0 at 30 s to 1.7 at 180 s. In this experiment, NOS was not
supplemented with BH4. Variable ratios were also observed
in a similar experiment in which NOS was supplemented with 1 mol of
BH4 per mol of NOS subunit. Under this condition the ratio
of BH4 oxidized to NHA formed was 3.1 at 30 s and
progressively decreased to 1.8 at 180 s (data not shown).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 5.
BH4 levels and NHA formation
under single turnover conditions. NOS was preincubated with NADPH
to maximize the level of FSQ. Reaction mixtures, which were not
supplemented with BH4, are described under "Experimental
Procedures." , values for BH4; , values for
NHA.
|
|
 |
DISCUSSION |
BH4 Oxidation during Continuous Turnover--
Under
continuous turnover conditions in the presence of an NADPH-regenerating
system (absence of arginine and BH4), oxidation of
NOS-bound BH4 is dependent upon the presence of
Ca2+/CaM and is prevented by SOD/catalase and by NNA.
Furthermore, BH4 can be regenerated upon addition of
SOD/catalase and NNA. These observations are consistent with the
oxidation of NOS-bound BH4 being mediated by
superoxide/peroxide, formed during the uncoupled reduction of oxygen by
heme-mediated transfer of electrons from NADPH (6, 28-30). The
oxidation state of NOS-bound BH4 appears to be determined
by a balance between BH4 oxidation by superoxide/peroxide on the one hand, and reductive regeneration of BH4 on the other.
For nNOS, added arginine and BH4 are known to increase the
coupling of oxygen reduction to NO formation at the expense of superoxide/peroxide formation (28, 30). We therefore expected that the
presence of arginine, especially in the presence of added BH4, would decrease the amount of BH4
oxidation. Instead, arginine appreciably increased BH4
oxidation (Fig. 2, curve 4 versus
curve 2; Fig. 3 curve 5 versus curve 3). The combined presence of
arginine and added BH4 initially delayed BH4
oxidation (Fig. 3, curve 6), but ultimately
BH4 was oxidized to the same low level as observed in the
presence of arginine alone. A likely interpretation of these effects is
that arginine facilitates the reduction of heme iron (34). Bearing in
mind that some superoxide is produced by nNOS even at saturating
concentrations of arginine and BH4 (31) and that NOS was
not completely saturated2 with added BH4, an
increase in heme reduction can lead not only to an increase in
(coupled) NO formation but also to an increase in (uncoupled) formation
of superoxide/peroxide and resultant increase in BH4
oxidation. Peroxynitrite can also be formed by reaction of superoxide
and NO (35). In the combined presence of arginine and BH4
(Fig. 3, curve 6), it is envisioned that the oxygenation at early times is largely coupled to NO formation, thereby
limiting the formation of superoxide and peroxynitrite required for
BH4 oxidation. As the incubation proceeds, formation of
superoxide/peroxynitrite and oxidation of BH4 resume, as
the level of BH4 is decreased to a level that is no
longer effective in coupling.
It is not entirely clear from these studies whether the increased
oxidation of BH4 in the presence of arginine reflects a donation of electrons by BH4 for arginine oxygenation. The
conditions of continuous turnover of NOS in this experiment, in which
BH4 is in a dynamic redox state, are not optimal for
assessing such a role for BH4; this role of BH4
is examined below in a more rigorous manner under single turnover
conditions. It is emphasized again that the arginine-stimulated
oxidation of BH4 under continuous turnover conditions is
sensitive to SOD/catalase. If SOD/catalase-sensitive oxidation of
BH4 is an essential step in arginine
oxygenation,3 product
formation by NOS would be expected to show a similar sensitivity. No
such inhibition of NOS by SOD has been observed (36-41).4 Limited reports in
the literature on the effects of catalase on NOS are conflicting. A
preliminary abstract (42) claimed that NO formation (measured by the
conversion of oxyhemoglobin to methemoglobin) catalyzed by NOS purified
from porcine brain was catalase-dependent. On the other
hand, Mittal (38) reported that NO formation (detected by activation of
guanylate cyclase) catalyzed by crude extracts of rat brain was
abolished by catalase. In neither of these studies did catalase affect
citrulline formation, in agreement with reports by other workers (11,
41, 43).
Other explanations for the effect of arginine during continuous
turnover of NOS are considered as follows.
(i) It is possible that the presence of arginine increases
BH4 oxidation by increasing the formation of peroxynitrite
at the expense of superoxide. As explained above, whereas superoxide is
the major product of oxygen reduction in the absence of arginine, the
presence of arginine allows both NO and superoxide to be formed. The
latter two compounds can react rapidly with each other to form
peroxynitrite (35). Peroxynitrite is generally considered to be a more
potent oxidant under physiological conditions than is superoxide or NO
(35). However, preliminary
studies5 on the oxidation of
1 mM BH4 in phosphate buffer (pH 7.6) showed comparable potencies for superoxide and peroxynitrite; hydrogen peroxide was relatively inactive, exhibiting an oxidation rate barely
exceeding that of autoxidation by oxygen. These observations argue
against an increased formation of peroxynitrite in the presence of
arginine causing the increased oxidation of NOS-bound BH4. It should be noted, however, that the rank order of potency determined in free solution may not be identical to that determined for NOS-bound BH4.
(ii) It is possible that the increased net oxidation of
BH4 in the presence of arginine can be explained by the
nature of the BH4 oxidation products and their recycling to
BH4. The nature of the product
(BH3· or qBH2) could be
affected by whether BH4 is oxidized by the obligate one
electron oxidant, superoxide (44), or by peroxynitrite, which can
catalyze one or two electron oxidations (45). Possible ways in which
each of these oxidized pterin products could be reduced to
BH4 are discussed below.
BH4 Oxidation under Single Turnover Conditions--
In
the single turnover system employed in the current work, it was
previously shown that FSQ can provide all the electrons required for
oxygenation of both arginine and NHA (21). Our NOS preparations contain
only one FSQ per NOS dimer, thereby raising the problem of explaining
the mechanism of delivery of the second electron required for arginine
oxygenation (21). These considerations suggested, and our preliminary
findings did not exclude, the possibility that compounds such as
BH4 might provide the second electron for arginine
oxygenation by reduction of the ferric superoxide heme species to the
ferric peroxo heme species (21). A similar proposal has recently been
made by Bec et al. (13) based on the results of single
turnover studies of the oxygenation of arginine to NHA supported by the
ferrous oxygen complex of nNOS.
It should be noted that the current single turnover experiments were
carried out under conditions that optimized the ability to detect any
coupling of the oxidation of BH4 to arginine oxygenation. Thus, any regeneration of BH4 from qBH2 was
suppressed by omission of an NADPH-regenerating system from the
reaction mixture. Furthermore, SOD and catalase were included in the
reaction mixture to minimize any oxidation of BH4 arising
from the accumulation of ROS (superoxide and hydrogen peroxide). SOD
and catalase were considered the best scavengers of ROS to be employed
in our single turnover studies, for the following reasons. (i) It is
generally believed that superoxide is a critical component of ROS and
that SOD provides the primary defense mechanism, with catalase and the
glutathione peroxidase/glutathione system sharing the task of
converting hydrogen peroxide to water and oxygen (46-48). As explained
below, it was not feasible to include both catalase and the glutathione
peroxidase/glutathione in our single turnover studies. (ii) SOD and
catalase are quite specific for superoxide and peroxides, respectively,
and are not known to catalyze reactions unrelated to their intended
use. (iii) SOD and catalase resulted in efficient, although possibly
not complete, scavenging ROS in our studies, even under the extreme conditions that favor the formation of superoxide and other ROS (Figs.
1 and 2). (iv) As previously explained in the discussion of
BH4 oxidation during continuous turnover, available
evidence indicates that neither SOD nor catalase inhibits arginine
oxygenation. (v) SOD and catalase do not interfere with the assay of
BH4 since they are removed from the reaction mixture by
precipitation with perchloric acid. Furthermore, SOD and catalase do
not interfere with any oxidation of BH4 coupled to arginine
oxygenation. This is not so with a number of other widely used
antioxidants. For example, the antioxidants ascorbate and thiols such
as glutathione regenerate BH4 from qBH2 (24,
49, 50) and could thus lead to an underestimation of the amount of
oxidation of BH4 under single turnover conditions.
Similarly, ferricytochrome c could not be used as a
scavenger of superoxide, because its oxidation of BH4 (51)
under our experimental conditions could not be excluded; such a
reaction would lead to an overestimation of any oxidation of
BH4 coupled to arginine oxygenation. Various nitroxides act as mimics of SOD, and their excellent cell permeability has led to
their extensive use as superoxide scavengers in biological systems.
These compounds are not an appropriate substitute for SOD in our
studies because the rate constants for reaction of superoxide with
these nitroxides are generally smaller by 3-5 orders of magnitude than
that with SOD (52).
The significantly greater oxidation of NOS-bound BH4 under
single turnover conditions in the presence of arginine (Fig. 4, curve 4) relative to NHA (Fig. 4, curve 3) is
indeed consistent with a scheme in which BH4 provides an
electron for arginine oxygenation but is not required for the one
electron-requiring oxygenation of NHA (53). A molar ratio for
BH4 oxidized/NHA formed of 0.5 is expected if the
two-electron oxidation of BH4 to qBH2 supplied only the second electron for NHA formation, and a ratio of 1.0 if
BH4 provided both electrons for NHA formation. The observed molar ratio was not constant but increased from 1.0 to 1.7 as the
reaction progressed (Fig. 5). This indicates that NOS-bound BH4 is able to provide all the electrons for oxygenation of
arginine to NHA. However, other pathways for BH4 oxidation
must operate in order to explain the high molar ratios of
BH4 oxidized per NHA formed at later incubation times and
the significant oxidation of BH4 in the absence of arginine
(Fig. 4, curve 2). Despite the efficiency of SOD and
catalase in scavenging ROS, it is important to note that a contribution
of ROS in the single turnover oxidation BH4 cannot be
definitively excluded.
Implications of the Redox Reactions of NOS-bound
BH4--
The cycling between BH4 and its
oxidized product(s) reported here is of major significance in that it
provides experimental support for a redox role of NOS-bound
BH4 and provides important insights toward defining the
mechanistic details of this redox role of BH4. The possible
significance of the oxidation of NOS-bound BH4 and
regeneration of the oxidized pterin products to BH4 is discussed separately below.
Our combined results are consistent with, but do not differentiate
between, the two mechanistic roles recently proposed for BH4 oxidation: as a reductant of oxygen (9), analogous to
its role in the aromatic amino acid hydroxylases (10), and as an electron donor for reducing the ferric heme superoxide species to the
ferric heme peroxo species in the oxygenation of arginine to NHA (13).
Two additional roles of BH4 oxidation that are consistent
with our findings should be mentioned. The first is based on the report
that the basal activity of NOS (measured in the absence of added
BH4) is positively correlated with the amount of bound
BH4 (6, 54). Oxidation of NOS-bound BH4 may
therefore act as a switch in shutting off the formation of toxic levels of peroxynitrite, formed by reaction of NO with superoxide, that results in a variety of pathophysiological conditions (55, 56). Whereas
superoxide could continue to be formed by the BH4-depleted enzyme (6, 28, 57), studies of the injury that occurs during postischemic myocardial reperfusion, for example, indicate that peroxynitrite was the oxidant species responsible (56). The second
suggested role for NOS-bound BH4 oxidation is that the reaction is coupled to the conversion of some group(s) on NOS to the
reduced form required for activity (11). A precedent for this model is
the reduction by BH4 of the inactive ferric form of
phenylalanine hydroxylase to the active ferrous form (58, 59). Our
current findings could reflect an analogous
Ca2+/CaM dependent reduction by
BH4 of some group(s) on NOS that must be in the reduced
form for catalytic activity.
Regardless of the specific role of electron donation by
BH4, regeneration of BH4 from its oxidized
product(s) probably plays a critical role in maintaining the pterin in
its active, reduced, form and provides experimental support for the
suggestion that BH4 recycling is involved in the higher and
more linear rates of NO formation in the presence of a
BH4-regenerating system such as dihydropteridine reductase
or reducing thiols (60-62). Unless qBH2 is effectively
reduced to BH4, it rapidly rearranges to
7,8-dihydrobiopterin (63, 64). The latter compound is not reduced by
NOS to BH4 (18), resulting in a net loss of BH4
from the enzyme.
The present work opens up a number of promising lines of research in
clarifying the redox role of BH4. For example, neither the
products of BH4 oxidation nor the mechanism of regeneration of BH4 from these products is understood. qBH2
is the usual product of enzymic oxidation of BH4, and
regeneration of BH4 from qBH2 is catalyzed by
dihydropteridine reductase (65). Regeneration of BH4 by
purified NOS proceeds in the absence of any added reductase, and must
therefore be catalyzed by an inherent reductase activity of NOS. NOS
does indeed catalyze the reduction of qBH2
(18). However, a number of observations cast doubt on the
physiological significance of this reduction. For example, very high
concentrations of qBH2 were required to achieve rates that
are comparable to those of NO synthesis, and the quinonoid form of
6-methyldihydropterin was more active than qBH2,
whereas the product of this reduction, 6-methyltetrahydropterin, shows
relatively little activation of NOS (18). An alternate proposal is that
BH4 cycles with the free radical,
BH3· (13, 15). There is no precedent
for the enzymic reduction of BH3·.
Possible mechanisms include direct reduction of
BH3· to BH4 (see Equation 1) (15) or the conversion of BH3· to
qBH2 and BH4 by dismutation (see Equation 2)
(66). Alternatively, BH3· can react
with oxygen to form qBH2 and hydrogen peroxide
(H2O2) (Equation 5, the sum of Equations 3 and
4) (67). Quinonoid BH2 formed in Equations 2-5 could be
further reduced to BH4 by an inherent dihydropterin
reductase activity of NOS.
|
(Eq. 1)
|
|
(Eq. 2)
|
|
(Eq. 3)
|
|
(Eq. 4)
|
|
(Eq. 5)
|
It is noteworthy that, at least under our particular continuous
turnover conditions in the presence of arginine, NOS appears to have a
limited capacity for regeneration of BH4 in relation to
BH4 oxidation. Only under conditions that severely inhibit superoxide formation (Fig. 2, curve 6) does
BH4 regeneration become the dominant reaction. However, our
current work did not allow quantitation of the relative rates of
oxidation of NOS-bound BH4 and regeneration of
BH4 from its oxidized products. Thus, BH4 regeneration observed on blocking the oxidation reaction was
essentially complete by the time the first sample was taken (Fig. 1,
curve 4, and Fig. 2, curve 6), and the
observed oxidation of BH4 in Figs. 1-3 is a composite of
both oxidation and reduction reactions. Such quantitations will be
invaluable in viewing the significance of the redox reactions of
BH4 in relation to overall NOS activity and to the
reduction of qBH2 by the "diaphorase activity" of NOS (18). A better understanding of these redox reactions might also help
clarify why the uncoupled reduction of molecular oxygen is much more
prominent with nNOS than with the other isozymes of NOS (reviewed in
Ref. 4).
 |
ACKNOWLEDGEMENTS |
We thank Drs. Bettie Sue Siler Masters and
Kirk McMillan for an inoculum of transfected human kidney 293 cells and
advice on their culture. We also thank Anna-Maria Vasquez for
outstanding tissue culture work.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Laboratory of
Neurochemistry, National Institute of Mental Health, Bldg. 36, Rm. 3D30, 36 Convent Dr. MSC 4096, Bethesda, MD 20892-4096. Tel.: 301-402-4896; Fax: 301-480-9284; E-mail: giovanel@codon.nih.gov.
2
It was calculated that supplementation with
BH4 resulted in 90% (presence of arginine) and 75%
(absence of arginine) of NOS subunits containing BH4. These
calculations were based on KD values of 37 nM
(presence of arginine) and 0.25 µM (absence of arginine)
determined for the dimer containing two bound BH4 molecules dissociating to the dimer containing a single bound BH4
molecule (68). Supplementation of reaction mixtures with higher
concentrations of BH4 was precluded because of the
resultant decreased sensitivity in the assay of BH4 oxidation.
3
Because the observed oxidation of
BH4 is the net result of the oxidation of BH4
and regeneration of its oxidized products, we cannot strictly exclude
the ad hoc proposal that an SOD-insensitive component of
BH4 oxidation is also present and that formation of the
oxidized product of BH4 by this component is balanced by reduction of this product to regenerate BH4.
4
The presence of SOD can inhibit citrulline
formation up to 60% (36, 37, 39), but this effect was explained by SOD
allowing the accumulation of the feedback inhibitor NO, rather than by a direct effect of SOD on the reactions of NO formation.
5
J. Giovanelli and S. Kaufman, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
NOS, nitric-oxide
synthase;
NO, nitric oxide;
BH4, 6-(L-erythro-1,2-dihydroxypropyl)-5,6,7,8-tetrahydropterin;
qBH2, quinonoid dihydrobiopterin;
BH3·, trihydrobiopterin radical;
CaM, calmodulin;
FSQ, the air-stable NOS-bound flavin semiquinone free
radical (FMNH·);
HPLC, high performance liquid chromatography;
SOD, superoxide dismutase;
NHA, NG-hydroxy-L-arginine;
NNA, NG-nitro-L-arginine;
nNOS, neuronal
NOS (NOS-I);
ROS, reactive oxygen species;
Bicine, N,N-bis(2-hydroxyethyl)glycine.
 |
REFERENCES |
| 1.
|
Griffith, O. W.,
and Stuehr, D. J.
(1995)
Annu. Rev. Physiol.
57,
707-736[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Feldman, P. L.,
Griffith, O. W.,
and Stuehr, D. J.
(1993)
Chem. Eng. News
71,
26-38
|
| 3.
|
Bredt, D. S.,
and Snyder, S. H.
(1994)
Annu. Rev. Biochem.
63,
175-195[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Gorren, A. C.,
and Mayer, B.
(1998)
Biochemistry (Mosc.)
63,
734-743[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Presta, A.,
Siddhanta, U.,
Wu, C.,
Sennequier, N.,
Huang, L.,
Abu-Soud, H. M.,
Erzurum, S.,
and Stuehr, D. J.
(1998)
Biochemistry
37,
298-310[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Gorren, A. C. F.,
List, B. M.,
Schrammel, A.,
Pitters, E.,
Hemmens, B.,
Werner, E. R.,
Schmidt, K.,
and Mayer, B.
(1996)
Biochemistry
35,
16735-16745[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Pfeiffer, S.,
Gorren, A. C. F.,
Pitters, E.,
Schmidt, K.,
Werner, E. R.,
and Mayer, B.
(1997)
Biochem. J.
328,
349-352
|
| 8.
|
Mayer, B.,
Wu, C. Q.,
Gorren, A. C. F.,
Pfeiffer, S.,
Schmidt, K.,
Clark, P.,
Stuehr, D. J.,
and Werner, E. R.
(1997)
Biochemistry
36,
8422-8427[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Rusche, K. M.,
Spiering, M. M.,
and Marletta, M. A.
(1998)
Biochemistry
37,
15503-15512[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Kaufman, S.
(1987)
Enzymes
18,
217-282
|
| 11.
|
Giovanelli, J.,
Campos, K. L.,
and Kaufman, S.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
7091-7095[Abstract/Free Full Text]
|
| 12.
|
Perry, J. M.,
and Marletta, M. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
11101-11106[Abstract/Free Full Text]
|
| 13.
|
Bec, N.,
Gorren, A. C. F.,
Voelker, C.,
Mayer, B.,
and Lange, R.
(1998)
J. Biol. Chem.
273,
13502-13508[Abstract/Free Full Text]
|
| 14.
|
Lewis, D. F. V.
(1996)
Cytochromes P450. Structure, Function and Mechanism
, pp. 79-113, Taylor & Francis Ltd., London
|
| 15.
|
Raman, C. S.,
Li, H.,
Martasek, P.,
Kral, V.,
Masters, B. S.,
and Poulos, T. L.
(1998)
Cell
95,
939-950[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Riethmuller, C.,
Gorren, A. C.,
Pitters, E.,
Hemmens, B.,
Habisch, H. J.,
Heales, S. J.,
Schmidt, K.,
Werner, E. R.,
and Mayer, B.
(1999)
J. Biol. Chem.
274,
16047-16051[Abstract/Free Full Text]
|
| 17.
|
Campos, K. L.,
Giovanelli, J.,
and Kaufman, S.
(1992)
in
The Biology of Nitric Oxide
(Moncada, S.
, Marletta, M. A.
, Hibbs, J. B., Jr.
, and Higgs, E. A., eds), Vol. 2
, pp. 47-50, Portland Press Ltd., London
|
| 18.
|
Witteveen, C. F. B.,
Giovanelli, J.,
and Kaufman, S.
(1996)
J. Biol. Chem.
271,
4143-4147[Abstract/Free Full Text]
|
| 19.
|
Kowlessur, D.,
Yang, X.,
and Kaufman, S.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4743-4747[Abstract/Free Full Text]
|
| 20.
|
Citron, B. A.,
Davis, M. D.,
and Kaufman, S.
(1992)
Protein Expression Purif.
3,
93-100[Medline]
[Order article via Infotrieve]
|
| 21.
|
Witteveen, C. F. B.,
Giovanelli, J.,
Yim, M. B.,
Gachhui, R.,
Stuehr, D. J.,
and Kaufman, S.
(1998)
Biochem. Biophys. Res. Commun.
250,
36-42[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Bredt, D. S.,
and Snyder, S. H.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
682-685[Abstract/Free Full Text]
|
| 23.
|
Fukushima, T.,
and Nixon, J. C.
(1980)
Anal. Biochem.
102,
176-188[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Kaufman, S.
(1961)
J. Biol. Chem.
236,
804-810[Free Full Text]
|
| 25.
|
Campos, K. L.,
Giovanelli, J.,
and Kaufman, S.
(1995)
J. Biol. Chem.
270,
1721-1728[Abstract/Free Full Text]
|
| 26.
|
Stuehr, D. J.,
and Ikeda-Saito, M.
(1992)
J. Biol. Chem.
267,
20547-20550[Abstract/Free Full Text]
|
| 27.
|
Gachhui, R.,
Presta, A.,
Bentley, D. F.,
Abu-Soud, H. M.,
McArthur, R.,
Brudvig, G.,
Ghosh, D. K.,
and Stuehr, D. J.
(1996)
J. Biol. Chem.
271,
20594-20602[Abstract/Free Full Text]
|
| 28.
|
Heinzel, B.,
John, M.,
Klatt, P.,
Böhme, E.,
and Mayer, B.
(1992)
Biochem. J.
281,
627-630
|
| 29.
|
Pou, S.,
Pou, W. S.,
Bredt, D. S.,
Snyder, S. H.,
and Rosen, G. M.
(1992)
J. Biol. Chem.
267,
24173-24176[Abstract/Free Full Text]
|
| 30.
|
Pou, S.,
Keaton, L.,
Surichamorn, W.,
and Rosen, G. M.
(1999)
J. Biol. Chem.
274,
9573-9580[Abstract/Free Full Text]
|
| 31.
|
Miller, R. T.,
Martasek, P.,
Roman, L. J.,
Nishimura, J. S.,
and Masters, B. S. S.
(1997)
Biochemistry
36,
15277-15284[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Abu-Soud, H. M.,
Feldman, P. L.,
Clark, P.,
and Stuehr, D. J.
(1994)
J. Biol. Chem.
269,
32318-32326[Abstract/Free Full Text]
|
| 33.
|
Furfine, E. S.,
Harmon, M. F.,
Paith, J. E.,
and Garvey, E. P.
(1993)
Biochemistry
32,
8512-8517[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Matsuoka, A.,
Stuehr, D. J.,
Olson, J. S.,
Clark, P.,
and Ikeda-Saito, M.
(1994)
J. Biol. Chem.
269,
20335-20339[Abstract/Free Full Text]
|
| 35.
|
Crow, J. P.,
and Beckman, J. S.
(1995)
Curr. Top. Microbiol. Immunol.
196,
57-73[Medline]
[Order article via Infotrieve]
|
| 36.
|
Hobbs, A. J.,
Fukuto, J. M.,
and Ignarro, L. J.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10992-10996[Abstract/Free Full Text]
|
| 37.
|
Schmidt, H. H. H. W.,
Hofmann, H.,
Schindler, U.,
Shutenko, Z. S.,
Cunningham, D. D.,
and Feelisch, M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
14492-14497[Abstract/Free Full Text]
|
| 38.
|
Mittal, C. K.
(1993)
Biochem. Biophys. Res. Commun.
193,
126-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Mayer, B.,
Klatt, P.,
Werner, E. R.,
and Schmidt, K.
(1995)
J. Biol. Chem.
270,
655-659[Abstract/Free Full Text]
|
| 40.
|
Xia, Y.,
and Zweier, J. L.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
12705-12710[Abstract/Free Full Text]
|
| 41.
|
Kim, S.-M.,
Byun, J.-S.,
Jung, Y.-D.,
Kang, I.-C.,
Choi, S.-Y.,
and Lee, K.-Y.
(1998)
Exp. Mol. Med.
30,
221-226[Medline]
[Order article via Infotrieve]
|
| 42.
|
Manitz, B.,
and Schrader, J.
(1992)
in
The Biology of Nitric Oxide
(Moncada, S.
, Marletta, M. A.
, Hibbs, J. B., Jr.
, and Higgs, E. A., eds), Vol. 2
, pp. 116-117, Portland Press Ltd., London
|
| 43.
|
Rengasamy, A.,
and Johns, R. A.
(1994)
Biochem. Pharmacol.
48,
423-425[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Fee, J. A.,
and Valentine, J. S.
(1977)
in
Superoxide and Superoxide Dismutases
(Micelson, A. M.
, McCord, J. M.
, and Fridovich, I., eds)
, pp. 19-60, Academic Press, New York
|
| 45.
|
Pryor, W. A.,
and Squadrito, G. L.
(1995)
Am. J. Physiol.
268,
L699-L722[Abstract/Free Full Text]
|
| 46.
|
Hassan, H. M.,
and Fridovich, I.
(1980)
in
Enzymatic Basis of Detoxication
(Jakoby, W. B., ed), Vol. 1
, pp. 311-332, Academic Press, New York
|
| 47.
|
Wendel, A.
(1980)
in
Enzymatic Basis of Detoxication
(Jakoby, W. B., ed), Vol. 1
, pp. 333-353, Academic Press, New York
|
| 48.
|
Halliwell, B.
(1995)
in
Active Oxygen in Biochemistry
(Valentine, J. S.
, Foote, C. S.
, Greenberg, A.
, and Liebman, J. F., eds)
, pp. 313-335, Blackie Academic and Professional Press, New York
|
| 49.
|
Kaufman, S.
(1959)
J. Biol. Chem.
234,
2677-2682[Free Full Text]
|
| 50.
|
Bublitz, C.
(1977)
Biochem. Med.
17,
13-19[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Katoh, S.,
Nagai, M.,
Nagai, Y.,
Fukushima, T.,
and Akino, M.
(1970)
in
Chemistry and Biology of Pteridines
(Iwai, K.
, Akino, M.
, Goto, M.
, and Iwanami, Y., eds)
, pp. 225-234, International Academic Printing Co. Ltd., Tokyo
|
| 52.
|
Krishna, M. C.,
and Samuni, A.
(1994)
Methods Enzymol.
234,
752-759
|
| 53.
|
Abu-Soud, H. M.,
Presta, A.,
Mayer, B.,
and Stuehr, D. J.
(1997)
Biochemistry
36,
10811-10816[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Hevel, J. M.,
and Marletta, M. A.
(1992)
Biochemistry
31,
7160-7165[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
Zhang, J.,
and Snyder, S. H.
(1995)
Annu. Rev. Pharmacol. Toxicol.
35,
213-233[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Wang, P.,
and Zweier, J. L.
(1996)
J. Biol. Chem.
271,
29223-29230[Abstract/Free Full Text]
|
| 57.
|
Xia, Y.,
Tsai, A. L.,
Berka, V.,
and Zweier, J. L.
(1998)
J. Biol. Chem.
273,
25804-25808[Abstract/Free Full Text]
|
| 58.
|
Marota, J. J.,
and Shiman, R.
(1984)
Biochemistry
23,
1303-1311[CrossRef][Medline]
[Order article via Infotrieve]
|
| 59.
|
Wallick, D. E.,
Bloom, L. M.,
Gaffney, B. J.,
and |